MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer. - Li H; Hong L; Rocha P; Bach R; Solis Soto LM; Rinsurongkawong W; Zhang B; Araujo HA; Elamin YY; Altan M; Arrechedera CA; Zhou J; et al. (Cancers, 2025)